Introduction

Bold hybrid care, simple logistics. We deliver lifelong allergy relief via telehealth and add in‑person steps only when they improve safety or outcomes.

Nationwide telehealth • Supervised first tablet dose (≥30 min) • Clinic coordination • 24/7 physician access • Ages 5+ • Environmental only

How the hybrid model works

• At‑home testing for 40+ environmental allergens (pets, pollens, dust mites, molds) with a CLIA‑certified finger‑prick blood test, then a virtual results review with a board‑certified physician. At‑home test and process, FAQs.

• Personalized sublingual immunotherapy (SLIT) care plan:

• Drops: daily at home; no in‑office monitoring required; safer risk profile than shots per major reviews. Immunotherapy overview, Are allergy drops safe?.

• Tablets (FDA‑approved for selected allergens): first dose is given under observation with ≥30 minutes of monitoring, then daily at home thereafter. SLIT tablets basics (UpToDate).

• Medicine shipped to your door every 12 weeks with unlimited 24/7 doctor access by text, call, email, or video. Unlimited access.

When we coordinate in‑person steps

• Supervised first tablet dose (≥30 minutes) when your plan uses FDA‑approved SLIT tablets; we arrange a convenient local clinic and share your plan and monitoring protocol. SLIT tablets basics (UpToDate).

• Rare exam needs: if your Wyndly physician identifies issues that benefit from an in‑person ENT/allergy exam (e.g., persistent sinus or breathing concerns), we’ll coordinate a referral and share your records to avoid duplicate work. “We’ll see you online. We’ll see you in the office.”

What stays virtual (and why)

• Testing logistics, results review, and treatment adjustments are highly suited to telehealth and continuous messaging. Consult flow.

• SLIT drops are designed for home use; major reviews support safety and efficacy without in‑office dosing. Cochrane‑summarized on Wyndly, AAO‑HNS recognition.

• Ongoing support: 24/7 access for questions, refills, side‑effect triage, and step‑ups. Patient FAQ.

Drops vs. tablets (at a glance)

Eligibility and safety

• Ages 5+; environmental allergies only (we don’t treat food allergies). Eligibility.

• Common contraindications: pregnancy, eosinophilic esophagitis (EoE), mast cell activation syndrome (MCAS), or use of beta blockers. Program FAQ.

• SLIT anaphylaxis risk is extremely low (on the order of 1 in 100 million); no reported SLIT‑drop fatalities. Safety data, Are drops safe?.

• U.S. only; care is delivered by board‑certified physicians with 24/7 on‑call coverage. About care access.

Pricing and insurance basics

• Treatment: $99/month (annual) or $110/month (quarterly), HSA/FSA eligible; unlimited physician access included; 90‑day Allergy‑Free Guarantee. Pricing details, Treatment subscription.

• Testing: at‑home blood test can be billed to insurance on eligible pages; self‑pay options available. Insurance‑billed test, At‑home test.

Outcomes and timelines

• First improvements commonly appear in 4–8 weeks; most patients notice clear benefits by 3–6 months. Time to benefit, Pollen SLIT timelines.

• Course length: ~3 years to lock in durable immune changes with potential decades of relief. Immunotherapy guide, Patient FAQ.

Evidence we follow

• Cochrane reviews and multi‑study summaries show SLIT is effective and safe for environmental allergies. Evidence summary.

• The American Academy of Otolaryngology recognizes SLIT’s role in allergy care. Professional recognition.

• SLIT tablets are FDA‑approved for select allergens and require first‑dose supervision, then daily home dosing. UpToDate SLIT tablets.

• The CDC highlights the large U.S. allergy burden—reinforcing the need for accessible, scalable care. CDC allergy stats.

Get started

• Book your virtual consult (ages 5+). Schedule.

• If needed, complete your at‑home test; meet your physician to finalize your plan. At‑home test.

• For tablet plans, we coordinate your supervised first dose; otherwise, begin home dosing with drops and message us anytime. Patient FAQs.